| Stage | DHR | % of rev | ROP | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.6B | 100.00% | $2.2B | 100.00% | DHR ×3.02 |
| Gross profit | $3.8B | 58.54% | $1.5B | 70.11% | ROP +11.6pp |
| Operating income | $1.2B | 19.00% | $623M | 28.70% | ROP +9.7pp |
| Pre-tax income | $1.1B | 17.27% | $572M | 26.34% | ROP +9.1pp |
| Net income | $1.2B | 18.84% | $485M | 22.32% | ROP +3.5pp |
| Stage | DHR | ROP | Gap · A − B |
|---|---|---|---|
| Revenue | $6.6B100.00% | $2.2B100.00% | DHR ×3.02 |
| Gross profit | 58.54%$3.8B | 70.11%$1.5B | ROP +11.6pp |
| Operating income | 19.00%$1.2B | 28.70%$623M | ROP +9.7pp |
| Pre-tax income | 17.27%$1.1B | 26.34%$572M | ROP +9.1pp |
| Net income |
| 18.84%$1.2B |
| 22.32%$485M |
| ROP +3.5pp |
No disclosed counterparties: DHR, ROP.